Decreased Serum 5‐ HT : Clinical Correlates and Regulatory Role in NMJ of MG
Annals of Clinical and Translational Neurology · 2026
DOI: 10.1002/acn3.70222 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, 2026. Verfasst von Xinru Shen und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroimmunology, Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: Myasthenia Gravis, Serotonin, Neuromuscular Junction. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Joint Research Special Project of National Center for Inheritance and Innovation of Traditional Chinese Medicine, National Major and Difficult Diseases Clinical Collaboration Project, The Basic Research Fund of Henan Institute of Medical and Pharmacological Sciences.
Abstract (Originalsprache)
Objective
Although 5‐Hydroxytryptamine (5‐HT) indirectly stimulates muscle contraction and participates in regulating Acetylcholine receptor (AChR) cluster homeostasis in cellular, animal, and clinical studies, evidence regarding its potential to modulate muscle contraction in myasthenia gravis (MG) remains limited. We aim to determine the levels of 5‐HT in MG and investigate its potential role as a regulatory neurotransmitter in promoting muscle contraction.
Methods
We collected serum from 109 patients with MG and 110 healthy volunteers, and recorded clinical variables, including myasthenia gravis classification (MGFA), quantitative myasthenia gravis score (QMG), and serological examination. The effects of 5‐HT on the neuromuscular junction (NMJ) were further identified using cellular and molecular experiments.
Results
In this study, we observed that serum 5‐HT levels decrease in patients with MG ( p < 0.0001) compared with disease‐free control. The thymoma‐associated complications alleviated this reduction ( p < 0.0001). Our functional studies showed that 5‐HT promotes the development of motor (cholinergic) neuron‐like axons and increases intracellular calcium peaks, which is proportional to the amount of neurotransmitter released ( p < 0.0001). AChR‐autoantibody treatment increases the expression of 5‐HT 2 R mRNA in muscle tube cells ( p < 0.001), and the downstream signaling pathway of 5‐HT 2 R is involved in the regulation of AChR cluster homeostasis.
Interpretation
This first report of clinical characteristics and serum 5‐HT levels from a cross‐sectional cohort study on MG suggests that 5‐HT plays a critical role in maintaining NMJ homeostasis. Additional cross‐sectional data on more MG phenotypes and longitudinal monitoring data are needed to explore the role of 5‐HT in the pathophysiological mechanisms of MG.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuroimmunology, Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.
- BGI College, Zhengzhou University, Zhengzhou, China.
- Department of Encephalopathy, First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China.
ORCID-Profile: Xinru Shen, Jie Lv, Feng Gao
Förderung
- Joint Research Special Project of National Center for Inheritance and Innovation of Traditional Chinese Medicine
- National Major and Difficult Diseases Clinical Collaboration Project
- The Basic Research Fund of Henan Institute of Medical and Pharmacological Sciences
- International Collaboration Fund for Creative Research Teams
- The Key Research and Development Projects of Henan Province Department of Science and Technology
- "Double First-Class" Initiative Construction Project of Traditional Chinese Medicine Discipline at Henan University of Chinese Medicine
- The Innovation Team Project of Shaanxi Provincial Department of Science and Technology
Zitieren
APA
Shen, X., Zhang, J., Zhou, X., Yu, X., Shang, H., Chen, S., Zhen, L., Wu, J., Hu, G., Zhu, X., Sun, Z., Wang, Y., Wang, J., Lv, J., Zhao, X., Zhang, Y., Guo, W., Peng, Y., & Gao, F. (2026). Decreased Serum 5‐ HT : Clinical Correlates and Regulatory Role in NMJ of MG. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.70222
Vancouver
Shen X, Zhang J, Zhou X, Yu X, Shang H, Chen S, et al. Decreased Serum 5‐ HT : Clinical Correlates and Regulatory Role in NMJ of MG. Annals of Clinical and Translational Neurology. 2026. doi:10.1002/acn3.70222
BibTeX
@article{Shen2026,
author = {Shen, Xinru and Zhang, Jing and Zhou, Xinyue and Yu, Xiaoxiao and Shang, Haodong and Chen, Shufan and Zhen, Lulu and Wu, Jinru and Hu, Guanlian and Zhu, Xiaoyan and Sun, Zhan and Wang, Yiren and Wang, Jiahui and Lv, Jie and Zhao, Xue and Zhang, Yingna and Guo, Wei and Peng, Ying and Gao, Feng},
title = {Decreased Serum 5‐ HT : Clinical Correlates and Regulatory Role in NMJ of MG},
journal = {Annals of Clinical and Translational Neurology},
year = {2026},
doi = {10.1002/acn3.70222}
}
EUVIMED